Complement Component C1q as a Potential Diagnostic Tool for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome...

Area of Science:

• Immunology
• Hematology
• Clinical Diagnostics

Background:

• Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) diagnosis relies solely on clinical symptoms.
• Blood tests currently only exclude other conditions causing fatigue.
• Limited research exists on comprehensive blood data analysis for ME/CFS subtyping.

Purpose of the Study:

• To explore ME/CFS case subgroups using unbiased cluster analysis of blood data.
• To identify potential blood biomarkers for ME/CFS classification.

Main Methods:

• Hierarchical cluster analysis applied to a cohort of 250 phenotyped female ME/CFS patients.
• Analysis of extensive blood datasets to identify patterns and correlations.

Main Results:

• Three distinct symptom clusters (severe, moderate, mild) were identified.
• Significant differences in five blood parameters were observed across clusters (p < 0.05).
• Elevated circulating complement factor C1q found in 43% of participants, correlating with increased pain symptoms.

Conclusions:

• Blood analytics can potentially stratify ME/CFS patients.
• Complement factor C1q may serve as a biomarker for a specific ME/CFS subgroup.
• Findings suggest implications for ME/CFS etiology research, diagnosis, and treatment development.